ÂÜÀòÂÒÂ×

Diana Borenshtein, Ph.D has a diverse and extensive work experience spanning over two decades. Diana has held various roles in different companies and organizations, showcasing their expertise in the field of health and life sciences.

Starting in 2023, Diana joined Kanda Software as the Vice President of Health and Life Sciences. Prior to this role, they served as a Life Sciences Business Development Consultant at the same company in 2022. Notably, they also held a similar position at Teknova in 2021, where they worked as the Director of Scientific Affairs.

Diana's career journey includes significant contributions at Miltenyi Biotec, starting from 2009. Diana demonstrated exceptional sales performance, achieving outstanding revenue growth, and consistently exceeding sales goals in various sales roles. Diana effectively managed academic and biopharmaceutical accounts, negotiated complex contracts, and developed new business opportunities. Diana also collaborated with cross-functional teams, participated in marketing and training material preparation, and coached and mentored team members.

Before joining Miltenyi Biotec, Diana worked at MIT as a Project Lab Instructor, a Postdoctoral Research Associate, and a Graduate Research Fellow. Their research focused on topics such as acute intestinal infection, animal models of infectious diseases, genomics, and mutagenesis.

Further back in their career, Diana was a Research Fellow at Biogen, where they made valuable contributions to research. Diana also worked as a Research Associate at Proneuron Biotechnologies, developing cell therapies for neuroprotection.

Diana's early career includes being a Research Associate (volunteer) at Stanford University and a Graduate Research and Teaching Assistant at The Hebrew University of Jerusalem's Faculty of Agriculture, Food, and Environment. Diana also served as a Consultant in Infant Nutrition at Israel Pharmaceutical Products, Maabarot Ltd.

Overall, Diana Borenshtein, Ph.D has a distinguished career in the health and life sciences sector, with a focus on sales, business development, scientific affairs, and research. Their experience spans from leadership roles to research and teaching positions, showcasing their versatility and expertise in the field.

Diana Borenshtein, Ph.D, completed their education in a chronological order. Diana obtained a Ph.D in Molecular and Systems Toxicology from the Massachusetts Institute of Technology (MIT) between 2001 and 2006. Prior to that, they earned an M.Sc.Nutr in Human Nutrition from The Hebrew University of Jerusalem from 1996 to 1999. Diana started their educational journey with a B.Sc.Nutr in Dietetics and Clinical Nutrition Services from The Hebrew University of Jerusalem, which they completed between 1991 and 1995. In addition to their formal education, Diana also obtained a certification from the MIT Sloan School of Management in their online program on Artificial Intelligence in Pharma and Biotech, although the specific year of completion is not provided.